Effects of the Immunocontraceptive Gonacon on Pregnancy in Brucella-Seropositive American bison (Bison bison)

J Wildl Dis. 2024 Apr 1;60(2):339-345. doi: 10.7589/JWD-D-21-00168.

Abstract

The purpose of this study was to determine if the number of pregnancies in naturally infected Brucella abortus-positive bison (Bison bison) cows would be reduced over a period of 5 yr after one treatment with 3000 µg gonadotropin-releasing hormone immunocontraceptive (GonaCon) compared to a similar group of naturally infected B. abortus-positive bison cows not treated with GonaCon. In each of the 5 yr, GonaCon-treated cows produced fewer offspring in relation to number of cows than the nontreated cows. Fisher's Exact test comparing offspring produced during the first reproductive season showed a significant difference between the two groups (P=0.0028). Differences in number of calves produced in GonaCon-treated and control groups were also noted in remaining years, but statistics were not applied because of data constraints. These data indicate that one treatment with GonaCon in brucellosis-seropositive female bison reduced pregnancies over five reproductive years. Thus, immunocontraception could potentially be used to manage brucellosis in affected herds.

Keywords: Brucella abortus; Bison; GnRH; GonaCon; immunocontraception; pregnancy.

MeSH terms

  • Animals
  • Antibodies, Bacterial
  • Bison*
  • Brucella abortus
  • Brucellosis* / veterinary
  • Cattle
  • Cattle Diseases*
  • Female
  • Pregnancy

Substances

  • Antibodies, Bacterial